Healthcare Policy Pop Podcast
1) QALY Ban Passes House š
On Wednesday morning, the House passed H.R. 485, the Protecting Care for All Patients Act, which bans the use of Quality-Adjusted Life Years (QALYs) in federal health programs. Bill Smith, a Senior Fe...Show More
2) QALY Ban Bill Progresses
Michael Riotto, a Patient Advocate and member of Patients Rising, tells us how the exciting developments with the QALY ban bill could affect him and his health if it moves forward. Riotto discusses ho...Show More
3) March-In Deadline Looms
Joe Allen, Executive Director of the Bayh-Dole Coalition, discusses a proposed framework announced by the Biden administration that would allow march-in rights to be used when a companyās drug price i...Show More
4) Policy Supports to Aging in Place
Dan Weinrieb, the Head of Strategic Partnerships at Jukebox Health, discusses aging at home and the federal policies that need to be improved in order to support it; and Stealth BioTherapeutics is con...Show More
5) Suspicious CVS Announcement š¤„
Alan Gilbert, Vice President for Policy at Purchaser Business Group on Health, discusses whether CVSās new pharmacy reimbursement model will provide transparency and decrease drug prices; and HHS has ...Show More
6) Why is Telehealth on the Hot Seat?
Kyle Zebley, Senior Vice President of Public Policy for the American Telemedicine Association, warns that the end of Telehealth care could be on the horizon. Learn why and what needs to be done to ext...Show More
7) āMarching-Inā A Step Too Far
MacKay Jimeson, Executive Director of Patients Rising, breaks down the most recent announcement from the White House that they may begin using their āmarch-inā rights on patents to try to curb drug pr...Show More
8) Beginning of the End for Alzheimer's
Mark Roithmayr, CEO of the Alzheimer's Drug Discovery Foundation, talks about the breakthroughs being made in Alzheimer's treatments and shows how these developments are right on time; and CVS is maki...Show More
9) Serving Up Justice š¼
Robert Salim, attorney at law and patient, discusses his legal fight with insurance to cover his medically necessary cancer treatments; and the Arizona Attorney General is suing insulin manufacturers ...Show More
10) Patient Groups Target ICER šÆ
Terry Wilcox, Patients Rising CEO, along with Rick Chapman, the Chief Science Officer at the Innovation and Value Initiative, and Darius Lakdawalla, the Chief Scientific Officer at EntityRisk, hold a ...Show More